Role of Artificial Intelligence in acromegaly detection and management

Clicks: 19
ID: 323147
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #263 of 449 articles by views in the journal of clinical endocrinology & metabolism

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 449 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Despite significant advances in the diagnosis and treatment of acromegaly, diagnostic delay remains substantial, often exceeding 6-10 years, while a significant proportion of patients remain inadequately controlled despite multiple available therapeutic modalities. Artificial intelligence (AI) is a promising tool to address several challenges across the acromegaly care pathway, from early disease detection to individualized treatment selection and outcome prediction. AI-assisted facial and hand image analysis has demonstrated the potential to identify subtle phenotypic changes and reduce diagnostic delay, facilitating earlier recognition of the disease. In parallel, machine learning and deep learning approaches have been increasingly employed to predict surgical remission, response to medical therapy, and radiotherapy outcomes, often outperforming individual biomarkers. AI models further support the development of precision medicine strategies capable of improving patient stratification and therapeutic decision-making. This review summarizes current and emerging applications of AI in acromegaly, including facial recognition technologies, radiomics and machine learning predictive models integrating clinical, biochemical, radiological, and molecular data.
Reference Key
openalex_W7171956802 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Leandro Kasuki, Eduardo Medeiros Ferreira da Gama, Luiz Eduardo Wildemberg
Are you one of these authors? Claim your profile
Journal the journal of clinical endocrinology & metabolism
Year 2026
DOI
10.1210/clinem/dgag311
URL
https://doi.org/10.1210/clinem/dgag311
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.